National Institutes of Health: Substance-Related Disorders trials

The registry lists 110 Substance-Related Disorders studies with National Institutes of Health as lead sponsor. 9 are open to participants now and 2 have results posted.

Phase 1 17Phase 2 27Phase 3 4Phase 4 12No phase 53(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1CompletedNCT00000318Phase 2
• Dextroamphetamine as an Adjunct in Cocaine Treatment - 1CompletedNCT00000304Phase 2
• Acute Withdrawal From Smoked Cocaine - 9CompletedNCT00000292Phase 1
• Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9CompletedNCT00000274Phase 2
• Pergolide Treatment for Substance Abusers - 4CompletedNCT00000269Phase 2
• Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1CompletedNCT00000245Phase 2
• Flupenthixol Decanoate in Methamphetamine Smoking - 1CompletedNCT00000241Phase 2
• Pharmacotherapy and Intensive Treatment - 2CompletedNCT00000218Phase 4
• Treatment Efficacy for Drug Abuse and AIDS Prevention - 2CompletedNCT00000211Phase 2
• Treatment Efficacy for Drug Abuse and AIDS Prevention - 1CompletedNCT00000210Phase 2